Platelet inhibition with cangrelor
- PMID: 20237353
- DOI: 10.1056/NEJMc1001127
Platelet inhibition with cangrelor
Comment on
-
Platelet inhibition with cangrelor in patients undergoing PCI.N Engl J Med. 2009 Dec 10;361(24):2318-29. doi: 10.1056/NEJMoa0908628. N Engl J Med. 2009. PMID: 19915221 Clinical Trial.
-
Intravenous platelet blockade with cangrelor during PCI.N Engl J Med. 2009 Dec 10;361(24):2330-41. doi: 10.1056/NEJMoa0908629. N Engl J Med. 2009. PMID: 19915222 Clinical Trial.
Similar articles
-
Platelet inhibition with cangrelor during PCI.N Engl J Med. 2013 Jul 25;369(4):393. doi: 10.1056/NEJMc1305978. N Engl J Med. 2013. PMID: 23883388 No abstract available.
-
Platelet inhibition with cangrelor during PCI.N Engl J Med. 2013 Jul 25;369(4):393-4. doi: 10.1056/NEJMc1305978. N Engl J Med. 2013. PMID: 23883387 No abstract available.
-
The duel between dual antiplatelet therapies.N Engl J Med. 2013 Apr 4;368(14):1356-7. doi: 10.1056/NEJMe1302504. Epub 2013 Mar 10. N Engl J Med. 2013. PMID: 23473370 No abstract available.
-
Management of Antiplatelet Allergy After Cardiac Stenting.JAMA Dermatol. 2016 Oct 1;152(10):1169-1170. doi: 10.1001/jamadermatol.2016.1983. JAMA Dermatol. 2016. PMID: 27332824 Review. No abstract available.
-
Cangrelor for the management and prevention of arterial thrombosis.Expert Rev Cardiovasc Ther. 2016 Sep;14(9):991-9. doi: 10.1080/14779072.2016.1207528. Epub 2016 Jul 8. Expert Rev Cardiovasc Ther. 2016. PMID: 27362653 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical